These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16264826)

  • 1. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.
    Keith WN; Bilsland A; Hardie M; Evans TR
    Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase and cancer: time to move from a promising target to a clinical reality.
    Keith WN; Jeffry Evans TR; Glasspool RM
    J Pathol; 2001 Nov; 195(4):404-14. PubMed ID: 11745671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-peritoneal administration of genetic therapies: promises and pitfalls.
    Evans TR; Keith WN
    Minerva Ginecol; 2004 Dec; 56(6):529-38. PubMed ID: 15729205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase and cancer.
    Harley CB; Kim NW
    Important Adv Oncol; 1996; ():57-67. PubMed ID: 8791128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of telomerase in cancer.
    Kim NW
    Eur J Cancer; 1997 Apr; 33(5):781-6. PubMed ID: 9282117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase as an anti-cancer drug target: will it fulfil its early promise?
    Newbold RF
    Anticancer Drug Des; 1999 Aug; 14(4):349-54. PubMed ID: 10625927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
    Kelland L
    Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies.
    Lund JR; Paoloni M; Kurzman I; Padilla M; Argyle DJ
    Vet J; 2008 Aug; 177(2):192-7. PubMed ID: 17981480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase as a new target for pancreatic cancer treatment.
    Sato N; Mizumoto K; Nagai E; Tanaka M
    J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
    Kyo S; Inoue M
    Oncogene; 2002 Jan; 21(4):688-97. PubMed ID: 11850797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase as a diagnostic and therapeutic target for cancer.
    Doyle LA; Highsmith WE
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):217-25. PubMed ID: 12113243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the telomere-telomerase hypothesis of aging and cancer.
    Holt SE; Shay JW; Wright WE
    Nat Biotechnol; 1996 Jul; 14(7):836-9. PubMed ID: 9631006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of telomerase-targeted therapies in canine cancer cell lines.
    Argyle DJ; McKevitt T; Gault E; Nasir L
    Vet Comp Oncol; 2004 Dec; 2(4):214-21. PubMed ID: 19379295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase is not an oncogene.
    Harley CB
    Oncogene; 2002 Jan; 21(4):494-502. PubMed ID: 11850774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell senescence and cancer.
    Mathon NF; Lloyd AC
    Nat Rev Cancer; 2001 Dec; 1(3):203-13. PubMed ID: 11902575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.